In a recent article published in the `Science’ magazine, titled ‘When the cure kills—CBD limits biodiversity research’, researchers have questioned the Convention on Biological Diversity (CBD), a framework formulated to conserve biodiversity.
Breast cancer remains a significant challenge, particularly in aggressive forms like triple-negative breast cancer (TNBC). This is a type of breast cancer where the tumour cells lack hormonal receptors, like estrogen receptors. This means that common breast cancer treatments targeting these receptors are not effective against TNBC, making it more challenging to treat and prone to spreading. Scientists are constantly searching for new ways to target the underlying mechanisms that allow these cancer cells to grow and spread unchecked.